Search results for

Statistical analyst Nate Silver says humility is key to making accurate predictions. Silver, who writes the New York Times' FiveThirtyEight blog, has just written a new book called The Signal and the Noise.

President Bush signs a housing bill that could help struggling homeowners stay in their homes and stabilize the nation's troubled housing market, while tightening regulation of Fannie Mae and Freddie Mac. NPR's Brian Naylor discusses the bill and explains the key points that every homeowner should know.

Is there a crisis of morale at the CIA? To some observers, news that an employee was fired last week for leaking classified information raises the question. Mary O. McCarthy was dismissed on Thursday, accused of leaking classified information about secret CIA prisons in Eastern Europe.

President Bush nominates Goldman Sachs Chairman Henry Paulson to be the new Treasury Secretary. He is to replace John Snow, whose resignation from the Cabinet will become official in June. Snow's departure had been widely expected.

The U.S. economy continued to lose jobs in May, but at a slower pace than it has been, giving credence to the idea that the recession is nearing an end. Still, the unemployment rate climbed to 9.4 percent, and wage growth has slowed to a trickle.

Federal Reserve Chair Jerome Powell signaled a rate cut in a key speech this morning. He was speaking at the annual Jackson Hole Economic Policy Symposium.

The Fed boosted a key interest rate again — its seventh hike since 2015. The move, which was expected, will trigger higher rates on credit cards, home equity lines and other kinds of borrowing.

For years, Republicans in Congress have been trying to cut Pentagon initiatives to fight extremism in the military. Now, the Trump administration may be poised to end those anti-extremism efforts.

Arizona is limiting new development in the Phoenix area because of anticipated groundwater shortages.

Drugs made from proteins or antibodies are difficult for rival manufacturers to copy. The Food and Drug Administration just approved a copycat drug for cancer patients that shows it can be done.